Literature DB >> 11916360

Apoptosis in cardiac disease--what is it--how does it occur.

M Neuss1, M T Crow, A Chesley, E G Lakatta.   

Abstract

This review will present a summary of a description of apoptotic pathways in the heart, followed by ways to measure it and the experimental and clinical evidence for the role of apoptosis in cardiac disease. An evaluation of the effectiveness of pharmacological and other therapeutic interventions in the prevention of apoptosis in the context of cardiac disease will also be presented.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11916360     DOI： 10.1023/a:1013715704835

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


  10 in total

Review 1.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

3.  Critical role for death-receptor mediated apoptotic signaling in viral myocarditis.

Authors:  Roberta L DeBiasi; Bridget A Robinson; J Smith Leser; R Dale Brown; Carlin S Long; Penny Clarke
Journal:  J Card Fail       Date:  2010-11       Impact factor: 5.712

4.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.

Authors:  Chi Keung Lam; Wen Zhao; Wenfeng Cai; Elizabeth Vafiadaki; Stela M Florea; Xiaoping Ren; Yong Liu; Nathan Robbins; Zhiguo Zhang; Xiaoyang Zhou; Min Jiang; Jack Rubinstein; W Keith Jones; Evangelia G Kranias
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

6.  Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: effects on programmed necrotic and apoptotic cell death.

Authors:  Adrian Szobi; Tomas Rajtik; Slavka Carnicka; Tana Ravingerova; Adriana Adameova
Journal:  Mol Cell Biochem       Date:  2013-12-18       Impact factor: 3.396

7.  [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.

Authors:  Dong Zhou; Wenhua Chu; Delphine L Chen; Qi Wang; David E Reichert; Justin Rothfuss; Andre D'Avignon; Michael J Welch; Robert H Mach
Journal:  Org Biomol Chem       Date:  2009-02-16       Impact factor: 3.876

8.  The ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosis.

Authors:  Rebecca L Scotland; Leah Allen; Leah J Hennings; Ginell R Post; Steven R Post
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

9.  Chinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats.

Authors:  Yanjun Cao; Xu He; Feng Lui; Zhuangzhuang Huang; Yanmin Zhang
Journal:  Exp Ther Med       Date:  2014-02-13       Impact factor: 2.447

10.  Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy.

Authors:  Zhong-Wei Liu; Hai-Tao Zhu; Kun-Lun Chen; Xin Dong; Jin Wei; Chuan Qiu; Jia-Hong Xue
Journal:  Cardiovasc Diabetol       Date:  2013-11-02       Impact factor: 9.951
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.